Vimarsana
Biggest News Aggregation in the World

Page 8 - Mathilde Bohin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mathilde Bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mathilde Bohin Today - Breaking & Trending Today

IMPLANET Reports Consolidated Revenue of €5.8 Million at September 30, 2021 up 34% - Vimarsana News

IMPLANET Reports Consolidated Revenue of €5.8 Million at September 30, 2021 up 34%

Q3 2021 revenue up 21% (vs. Q3 2020) to €2.1 million Buoyant growth of 49% to €1.8 million in Spine activity in Q3 2021 (vs. Q3 2020) and +61% to €4.3 million over the first 9 months of 2021

GeNeuro : Availability of documents and information for the annual shareholders' meeting of May 27, 2021 - Vimarsana News

GeNeuro : Availability of documents and information for the annual shareholders' meeting of May 27, 2021

for the annual shareholders' meeting of May 27, 2021 Geneva, Switzerland, May 6, 2021 - 6:00pm CEST - GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurologic and autoimmune diseases, including multiple sclerosis, informs its shareholders that the Annual General Meeting will be held on Thursday May 27, 2021 at 9.30am at its head office, 3, chemin du Pré-Fleuri,1228 Plan-les-Ouates, Geneva, Switzerland. Based on article 27 of Ordinance 3 on Measures to combat the Coronavirus of 19 June 2020 (COVID- 19 Ordinance...

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 27, 2021 - Vimarsana News

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 27, 2021

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 27, 2021 Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company developing new treatments for neurologic and autoimmune diseases, including multiple sclerosis, informs its shareholders that the Annual General Meeting will be held on Thursday May 27, 2021 at 9.30am at its head office, 3, chemin du Pré-Fleuri, 1228 Plan-les-Ouates, Geneva, Switzerland. Based on article 27 of Ordinance 3 on Measures to combat the Coronavirus of 19 June 2020 (COVID-19 Ordinance 3, sta...

Second call of Implanet's AGM on 18 May 2021 at 14:00 - Vimarsana News

Second call of Implanet's AGM on 18 May 2021 at 14:00

Live presentation of the AGM via web conference https://us02web.zoom.us/webinar/register/WN_ykfVpnaURqCe3afIQ-Otsg Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for

ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 ... - Vimarsana News

ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 ... Erytech Pharma S.A.April 28, 2021 GMT ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details Publication of Q1 2021 results on 4 May 2021 after market close Lyon (France) and Cambridge, MA (U.S.), April 29, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red b...

Source: apnews.com